Drug intelligence / Profile preview

Arthrorell N

Development stage: Unknown
Lead developer: Sanorell Pharma
Administration: Oral

Overview

Arthrorell N is a homeopathic complex preparation developed by Sanorell Pharma, indicated for the symptomatic treatment of rheumatic joint diseases. It is administered as oral drops and contains a mixture of six homeopathic active ingredients: Berberis vulgaris, Acidum silicicum, Calcium phosphoricum, Ledum palustre, Rhus toxicodendron, and Symphytum officinale. The product is registered in Germany as a homeopathic medicinal product. Its action is based on the principles of homeopathy, aiming to stimulate the body's self-healing processes through highly diluted substances. It is primarily used to improve complaints associated with chronic inflammatory or degenerative joint conditions such as arthritis and rheumatism.

Brand names: Arthrorell N
Other names: Arthrorell N TropfenArthrorell N Mischung

Beyond the preview

Go deeper on Arthrorell N.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arthrorell N.

Explore the full profile